COX-2 inhibitors - Reply

被引：2
|
作者：
Hawkey, CJ [1 ]
机构：
[1] Univ Nottingham Hosp, Sch Med & Surg Sci, Div Gastroenterol, Nottingham NG7 2UH, England
来源：
LANCET | 1999年 / 353卷 / 9162期
关键词：
D O I：
10.1016/S0140-6736(05)75962-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1440 / 1440
页数：1
相关论文
共 50 条
  • [41] COX-2 inhibitors in rheumatoid arthritis
    Sundy J.S.
    Current Rheumatology Reports, 2001, 3 (1) : 86 - 91
  • [42] COX-2 inhibitors and cardiovascular risk
    Funk, Colin D.
    FitzGerald, Garret A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
  • [43] COX-2 inhibitors with a methylsulfoxide pharmacophore
    Chung, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) : 617 - 620
  • [44] COX-2 selective inhibitors and bone
    Goodman, SB
    Ma, T
    Genovese, M
    Smith, RL
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (03): : 201 - 205
  • [45] COX-2 inhibitors for colorectal cancer
    Douglas J. E. Elder
    Christos Paraskeva
    Nature Medicine, 1998, 4 : 392 - 393
  • [46] The potential danger of COX-2 inhibitors
    Norman, RJ
    Wu, RJ
    FERTILITY AND STERILITY, 2004, 81 (03) : 493 - 494
  • [47] Are COX-2 selective inhibitors nephrotoxic?
    Dunn, MJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 976 - 977
  • [48] Clinical aspects of COX-2 inhibitors
    Emery, P
    DRUGS OF TODAY, 1999, 35 (4-5) : 267 - 274
  • [49] COX-2 inhibitors safety question
    Dorey, E
    CHEMISTRY & INDUSTRY, 2004, (20) : 6 - 6
  • [50] Current status of COX-2 inhibitors
    Singh, Palwinder
    Mittal, Anu
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (01) : 73 - 90
12345